12.35
price down icon3.29%   -0.42
after-market アフターアワーズ: 12.50 0.15 +1.21%
loading
前日終値:
$12.77
開ける:
$12.75
24時間の取引高:
945.34K
Relative Volume:
0.66
時価総額:
$1.28B
収益:
当期純損益:
$-135.21M
株価収益率:
-8.6297
EPS:
-1.4311
ネットキャッシュフロー:
$-114.35M
1週間 パフォーマンス:
+3.00%
1か月 パフォーマンス:
-1.52%
6か月 パフォーマンス:
+20.72%
1年 パフォーマンス:
-7.14%
1日の値動き範囲:
Value
$12.03
$12.75
1週間の範囲:
Value
$11.20
$12.89
52週間の値動き範囲:
Value
$7.23
$14.68

Oric Pharmaceuticals Inc Stock (ORIC) Company Profile

Name
名前
Oric Pharmaceuticals Inc
Name
セクター
Healthcare (1052)
Name
電話
(650) 388-5600
Name
住所
240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA
Name
職員
104
Name
Twitter
Name
次回の収益日
2026-11-12
Name
最新のSEC提出書
Name
ORIC's Discussions on Twitter

Compare ORIC vs VRTX, MRNA, REGN, ARGX, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ORIC icon
ORIC
Oric Pharmaceuticals Inc
12.35 1.28B 0 -135.21M -114.35M -1.4311
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
499.74 126.66B 12.34B 4.34B 3.71B 16.87
MRNA icon
MRNA
Moderna Inc
218.01 87.04B 2.23B -3.19B -1.60B -8.1462
REGN icon
REGN
Regeneron Pharmaceuticals Inc
790.74 81.41B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
819.14 51.51B 4.16B 1.29B 734.26M 19.58
ONC icon
ONC
Beone Medicines Ltd Adr
369.06 41.75B 5.76B 514.49M 1.10B 4.4813

Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-10-05 開始されました Leerink Partners Outperform
2026-09-23 開始されました BTIG Research Buy
2026-06-12 再開されました Stifel Buy
2026-05-15 アップグレード Goldman Neutral → Buy
2026-01-07 開始されました Piper Sandler Overweight
2025-11-20 開始されました Evercore ISI Outperform
2025-11-18 開始されました Wolfe Research Peer Perform
2025-09-04 再開されました Guggenheim Buy
2025-07-08 開始されました Ladenburg Thalmann Buy
2024-10-31 開始されました Wells Fargo Overweight
2024-09-06 開始されました Stifel Buy
2024-02-23 開始されました Cantor Fitzgerald Overweight
2023-09-22 開始されました Wedbush Outperform
2023-03-23 アップグレード H.C. Wainwright Neutral → Buy
2023-03-21 アップグレード Guggenheim Neutral → Buy
2023-03-16 アップグレード Oppenheimer Perform → Outperform
2022-07-18 再開されました Oppenheimer Perform
2022-04-04 アップグレード Citigroup Neutral → Buy
2022-03-25 ダウングレード H.C. Wainwright Buy → Neutral
2022-03-22 ダウングレード Citigroup Buy → Neutral
2022-03-22 ダウングレード Guggenheim Buy → Neutral
2022-03-22 ダウングレード Oppenheimer Outperform → Perform
2021-07-06 アップグレード Citigroup Neutral → Buy
2021-01-25 ダウングレード Citigroup Buy → Neutral
2020-08-13 開始されました Robert W. Baird Outperform
2020-08-06 アップグレード Citigroup Neutral → Buy
2020-08-03 開始されました H.C. Wainwright Buy
2020-05-19 開始されました Citigroup Neutral
2020-05-19 開始されました Guggenheim Buy
2020-05-19 開始されました JP Morgan Overweight
2020-05-19 開始されました Jefferies Buy
すべてを表示

Oric Pharmaceuticals Inc (ORIC) 最新ニュース

pulisher
Oct 13, 2026

Oric Pharmaceuticals director Heyman sells $86,524 in ORIC stock By Investing.com - Investing.com South Africa

Oct 13, 2026
pulisher
Oct 12, 2026

Form 4 Oric Pharmaceuticals Inc: Richard A. Heyman (Director) For: 1 October - Investing.com UK

Oct 12, 2026
pulisher
Oct 05, 2026

Cancer Research UK will fund early testing of a potential cancer treatment. - stocktitan.net

Oct 05, 2026
pulisher
Oct 02, 2026

A director exercised options at $1.60 and sold 3,500 Oric Pharmaceuticals (ORIC) shares. - Stock Titan

Oct 02, 2026
pulisher
Oct 02, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Oct 02, 2026
pulisher
Oct 02, 2026

Six new hires received options to buy shares and stock awards from ORIC Pharmaceuticals - Stock Titan

Oct 02, 2026
pulisher
Oct 02, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Oct 02, 2026
pulisher
Oct 01, 2026

A director proposes selling 8,100 shares of Oric Pharmaceuticals (ORIC). - Stock Titan

Oct 01, 2026
pulisher
Oct 01, 2026

A proposed sale covers 7,600 Oric Pharmaceuticals (ORIC) shares held by RAHD Capital. - Stock Titan

Oct 01, 2026
pulisher
Sep 29, 2026

Oric Pharma CFO sells $181k in shares By Investing.com - Investing.com South Africa

Sep 29, 2026
pulisher
Sep 29, 2026

Form 4 Oric Pharmaceuticals Inc For: 29 September By Investing.com - Investing.com Nigeria

Sep 29, 2026
pulisher
Sep 29, 2026

Oric Pharma CFO sells $181k in shares - Investing.com

Sep 29, 2026
pulisher
Sep 29, 2026

Form 4 Oric Pharmaceuticals Inc For: 29 September - Investing.com India

Sep 29, 2026
pulisher
Sep 29, 2026

Form 4 Oric Pharmaceuticals Inc For: 29 September By Investing.com - Investing.com UK

Sep 29, 2026
pulisher
Sep 29, 2026

After a $4.36 option exercise, Oric Pharmaceuticals (ORIC) CFO sells 13,400 shares. - stocktitan.net

Sep 29, 2026
pulisher
Sep 29, 2026

Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Stock Has Average Target Price of $20.18 - MarketBeat

Sep 29, 2026
pulisher
Sep 26, 2026

1,078,055 Shares of Oric Pharmaceuticals, Inc. $ORIC Purchased by Bank of America Corp DE - MarketBeat

Sep 26, 2026
pulisher
Sep 25, 2026

Oric Pharmaceuticals CFO Dominic Piscitelli sells $8,102 in shares - Investing.com

Sep 25, 2026
pulisher
Sep 25, 2026

Oric Pharmaceuticals CFO Dominic Piscitelli sells $8,102 in shares By Investing.com - Investing.com Canada

Sep 25, 2026
pulisher
Sep 25, 2026

Form 4 Oric Pharmaceuticals Inc For: 25 September By Investing.com - Investing.com Canada

Sep 25, 2026
pulisher
Sep 25, 2026

Form 4 Oric Pharmaceuticals Inc For: 25 September By Investing.com - Investing.com India

Sep 25, 2026
pulisher
Sep 25, 2026

A finance chief exercised 600 options and sold 600 shares at Oric Pharmaceuticals (ORIC). - stocktitan.net

Sep 25, 2026
pulisher
Sep 25, 2026

Form 4 Oric Pharmaceuticals Inc For: 25 September By Investing.com - Investing.com UK

Sep 25, 2026
pulisher
Sep 21, 2026

ORIC Pharmaceuticals (Nasdaq:ORIC)Stock Analysis - Simply Wall Street

Sep 21, 2026
pulisher
Sep 18, 2026

Oric Pharmaceuticals Inc (NYSE: ORIC) Share Price, ORIC Stock News, ORIC Share Price & Updates - kalkine.com.au

Sep 18, 2026
pulisher
Sep 13, 2026

Squarepoint Ops LLC Purchases Shares of 344,343 Oric Pharmaceuticals, Inc. $ORIC - marketbeat.com

Sep 13, 2026
pulisher
Sep 12, 2026

Precision Trading with Oric Pharmaceuticals Inc. (ORIC) Risk Zones - Stock Traders Daily

Sep 12, 2026
pulisher
Sep 10, 2026

ORIC: Advancing late-stage prostate and lung cancer programs with robust funding and global trials - TradingView

Sep 10, 2026
pulisher
Sep 10, 2026

ORIC: Phase III trials and robust funding position support late-stage oncology pipeline growth - TradingView

Sep 10, 2026
pulisher
Sep 09, 2026

ORIC Pharmaceuticals at Wells Fargo conference: late-stage pipeline in focus - Investing.com Canada

Sep 09, 2026
pulisher
Sep 09, 2026

ORIC Pharmaceuticals at Wells Fargo conference: late-stage pipeline in focus - Investing.com India

Sep 09, 2026
pulisher
Sep 09, 2026

Oric Pharmaceuticals joins 2026 Cantor Global Healthcare Conference fireside chat: Can ORIC break above $12.51? - Traders Union

Sep 09, 2026
pulisher
Sep 09, 2026

ORIC: Advancing late-stage cancer therapies with strong efficacy, safety, and major market potential - TradingView

Sep 09, 2026
pulisher
Sep 07, 2026

Enterprise value to revenue forward of Oric Pharmaceuticals, Inc. – NASDAQ:ORIC - TradingView

Sep 07, 2026
pulisher
Sep 07, 2026

Enterprise value to revenue forward of Oric Pharmaceuticals, Inc. – MUN:4TZ - TradingView

Sep 07, 2026
pulisher
Sep 05, 2026

ORIC stock holds steady as biotech eyes next trial and earnings - AD HOC NEWS

Sep 05, 2026
pulisher
Sep 04, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Sep 04, 2026
pulisher
Sep 04, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Sep 04, 2026
pulisher
Sep 03, 2026

Himalayas-1: Bayer and ORIC Double Down on Prostate Cancer With New Phase 3 Combo Trial - TipRanks

Sep 03, 2026
pulisher
Sep 02, 2026

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences - Yahoo Finance

Sep 02, 2026
pulisher
Sep 02, 2026

ORIC stock holds firm as biotech valuation nears 0.93 billion USD - ad-hoc-news.de

Sep 02, 2026
pulisher
Sep 02, 2026

(ORIC) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Sep 02, 2026
pulisher
Sep 01, 2026

Oric Pharmaceuticals Inc (NYSE: ORIC) Share Price, ORIC Stock News, ORIC Share Price & Updates - kalkine.ca

Sep 01, 2026
pulisher
Aug 31, 2026

Oric Pharmaceuticals stock holds above $13 as BlackRock boosts stake - ad-hoc-news.de

Aug 31, 2026
pulisher
Aug 28, 2026

Oric Pharmaceuticals (NASDAQ: ORIC) CFO sells 77,000 shares - Stock Titan

Aug 28, 2026
pulisher
Aug 28, 2026

Oric Pharmaceuticals Insider Sold Shares Worth $1,053,814, According to a Recent SEC Filing - Yahoo Finance

Aug 28, 2026
pulisher
Aug 26, 2026

ORIC Pharmaceuticals (NASDAQ: ORIC) officer plans $3.1M stock sale - Stock Titan

Aug 26, 2026
pulisher
Aug 21, 2026

Blue Owl Capital Holdings LP Invests $4.33 Million in Oric Pharmaceuticals, Inc. $ORIC - MarketBeat

Aug 21, 2026
pulisher
Aug 20, 2026

Oric Pharmaceuticals (NASDAQ:ORIC) Sets New 12-Month HighHere's Why - MarketBeat

Aug 20, 2026
pulisher
Aug 19, 2026

Oric (ORIC) Earnings Report: EPS Misses Its Estimate in Latest Trading; After Earnings: The Stock Gains 4.04% in the Latest SessionForward EPS Estimate - vinanet.vn

Aug 19, 2026

Oric Pharmaceuticals Inc (ORIC) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Oric Pharmaceuticals Inc (ORIC) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Richard A, Heyman
Director
Oct 01 '26
Proposed Sale
13.47
8,100
109,107
0
Richard A, Heyman
Director
Oct 01 '26
Proposed Sale
13.47
7,600
102,372
0
Heyman Richard A.
Director
Oct 01 '26
Sale
12.91
3,500
45,199
38,300
Heyman Richard A.
Director
Oct 01 '26
Sale
12.91
3,200
41,325
203,472
Piscitelli Dominic
Chief Financial Officer
Sep 28 '26
Sale
13.53
13,400
181,258
69,828
Piscitelli Dominic
Chief Financial Officer
Sep 28 '26
Option Exercise
4.36
13,400
58,424
83,228
Piscitelli Dominic
Chief Financial Officer
Sep 24 '26
Sale
13.50
600
8,102
69,828
Piscitelli Dominic
Chief Financial Officer
Sep 24 '26
Option Exercise
4.36
600
2,616
70,428
Dominic Piscitelli
Officer
Aug 26 '26
Proposed Sale
13.50
229,500
3,098,250
0
Piscitelli Dominic
Chief Financial Officer
Aug 26 '26
Sale
13.69
77,000
1,053,814
69,828
$18.52
price down icon 2.73%
$18.15
price down icon 3.51%
$89.83
price down icon 0.74%
$27.57
price down icon 6.76%
$34.46
price down icon 4.38%
$35.78
price down icon 5.14%
大文字化:     |  ボリューム (24 時間):